Description
Envarsus (Tacrolimus) Tablets with Prolonged Release 0.75 mg. – 30 Tablets
Introduction:
Envarsus is a medication that contains tacrolimus, an immunosuppressant drug used to prevent organ rejection in transplant patients. These tablets are formulated with prolonged release technology to provide a steady and consistent dose of medication over a specified period of time. Each tablet contains 0.75 mg. of tacrolimus and comes in a pack of 30 tablets.
Uses:
Envarsus is primarily used to prevent rejection of transplanted organs such as the kidney, liver, or heart. It works by suppressing the body’s immune response to the new organ, reducing the risk of the body attacking and rejecting the transplant. This medication is typically prescribed to transplant recipients as part of their post-transplant immunosuppressive regimen.
How to Take:
It is important to follow your healthcare provider’s instructions when taking Envarsus. The usual dosage is determined based on your medical condition, response to treatment, and other medications you may be taking. The tablets should be taken orally with or without food, usually once daily at the same time each day. Do not crush or chew the tablets; swallow them whole with a glass of water.
Precautions:
Before taking Envarsus, inform your doctor about any allergies you may have, your medical history, and the medications you are currently taking. This medication may interact with other drugs, so it is important to disclose all prescription, non-prescription, and herbal products you are using. Avoid grapefruit or grapefruit juice while taking Envarsus as it may increase the risk of side effects.
Side Effects:
Common side effects of Envarsus may include headache, nausea, diarrhea, stomach pain, or tremors. Notify your healthcare provider if these side effects persist or worsen. Serious side effects such as signs of infection, unusual tiredness, persistent nausea or vomiting, or changes in vision should be reported immediately.
Storage:
Store Envarsus tablets at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Do not use Envarsus after the expiration date printed on the packaging.
Conclusion:
Envarsus tablets with prolonged release 0.75 mg. are an important medication for transplant recipients to prevent organ rejection. By following your doctor’s instructions and taking the medication as prescribed, you can help ensure the success of your transplant and maintain your overall health. If you have any concerns or questions about Envarsus, consult your healthcare provider for further guidance.
